Marc S. Raab, M.D.^1*, Niels Weinhold, PhD^2*, K. Martin Kortüm, MD^3*, Jan Krönke, MD^4,5, Lilli Podola^6*, Uta Bertsch, MD^6*, Jan H. Frenking, MD^2*, Julia Mersi, MD^7*, Stefanie Huhn, PhD^6*, Michael Hundemer, MD^6*, Gunhild Mechtersheimer, MD^8*, Roland Fenk, MD, PhD^9*, Katja C. Weisel, MD¹⁰, Natalie Schub^11*, Florian Bassermann, MD^12*, Monika Engelhardt, MD¹³, Raphael Teipel, MD^14*, Mathias Hänel, MD¹⁵, Hans Salwender, MD^16*, Bas D Koster, MD, PhD¹⁷, Elena Ershova^18*, Caline Sakabedoyan^19*, Isobel Barrott^20*, Agnes Balogh^18*, Sanjay Vara, BSc^20*, Tobias Kampfenkel, MD, MHBA^21*, Hartmut Goldschmidt, MD¹, Hermann Einsele, MD⁷ and Leo Rasche, MD^7*

¹Heidelberg Myeloma Center, Heidelberg, Germany
²Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
³Department of Internal Medicine II, University Hospital of Würzburg, Wuerzburg, Germany
⁴Ulm University, Ulm, Germany
⁵Department for Hematology, Oncology, and Tumor Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany
⁶Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁷Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
⁸Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
⁹Department for Hematology, Oncology and Clinical Immunology, Medical Faculty, Heinrich Heine University Dusseldorf, Moorenstr. 5, 40225, Hamburg, Germany
¹⁰University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
¹¹Department of Internal Medicine II, Division of Stem Cell Transplantation and Immunotherapy, UKSH Campus, Kiel, Germany
¹²Department of Medicine III, Klinikum Rechts der Isar, Technische Universität München, München, Germany German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
¹³Department of Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
¹⁴Medizinische Klinik und Poliklinik 1, Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Germany
¹⁵Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
¹⁶Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany
¹⁷Janssen Research & Development, LLC, Leiden, Netherlands
¹⁸Janssen Research & Development, LLC, Beerse, Belgium
¹⁹Janssen Research & Development, LLC, Paris, France
²⁰Janssen Research & Development, LLC, High Wycombe, United Kingdom
²¹Janssen Research & Development, Neuss, Germany

Elena Zamagni, MD^1*, Tobias Silzle, MD^2*, Ivan Špička^3*, Sabrin Tahri, MD^4*, Sarah Lonergan^4*, Inger S. Nijhof, MD, PhD^5*, Antonietta Pia Falcone, MD, PhD^6*, Evangelos Terpos^7*, Jakub Radocha, MD, PhD^8*, Roberto Mina^9*, Guldane Cengiz Seval, MD^10*, Meral Beksac, MD¹¹, Cesar Rodriguez, MD^12*, Marcelo C. Pasquini, MD, MS^13,14, Michel Delforge^15*, Vania Hungria, MD, PhD¹⁶, Donna Reece, MD¹⁷, Philippe Moreau, MD, PhD^18*, Yael C. Cohen¹⁹, Kihyun Kim, MD^20*, Dominik Dytfeld^21*, Jiří Minařík²², Irene Strassl^23*, Jelena Bila, MD^24*, Martin Schreder, MD^25*, Janusz Krawczyk, MD²⁶, Fredrik Schjesvold, MD, PhD²⁷, Caroline Cicin-Sain^28*, Christoph Driessen²⁹, Gordon Cook^30*, Lugui Qiu, MD³¹, Gonzalo Martin Garate, MD^32*, Agoston Gyula Szabo, MD, PhD³³, Roman Hájek³⁴, Marc S. Raab, M.D.^35*, Silvia Mangiacavalli, MD^36*, Hermann Einsele, MD³⁷, Andrew Spencer, MBBS^38*, Mario Boccadoro, MD^39,40, Helen Vassalou^41*, Lixia Pei^42*, Yingqi Shi^43*, Maria Krevvata, PhD^44*, Ryan Gruber^44*, Caline Sakabedoyan^45*, Margaret Cobb^46*, Jagoda Jasielec^43*, Himal Amin^43*, Rachel Kobos, MD⁴³, Pieter Sonneveld, MD⁴⁷ and Niels W.C.J. van de Donk, MD, PhD^48*

¹IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", and Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
²Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
³Charles University and General Hospital, Prague, Czech Republic
⁴European Myeloma Network, Rotterdam, Netherlands
⁵Department of Internal Medicine-Hematology, St Antonius Hospital Nieuwegein, Nieuwegein, Netherlands
⁶Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, Unità di Ematologia, San Giovanni Rotondo, Italy
⁷University of Athens, School of Medicine, Athens, Greece
⁸4th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University Czech Republic, Hradec Kralove, Czech Republic
⁹AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
¹⁰Department of Hematology, Ankara University Faculty of Medicine, Department of Hematology, Mamak, Ankara, Turkey
¹¹Department of Hematology, Ankara University Faculty of Medicine, Department of Hematology, Ankara, Turkey
¹²Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹³Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁴Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹⁵University of Leuven, Leuven, Belgium
¹⁶Clinica São Germano, São Paulo, Brazil
¹⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁸University Hospital Hôtel-Dieu, Nantes, France
¹⁹Department of Hematology, Tel-Aviv Sourasky (Ichilov) Medical Center, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²⁰Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
²¹The Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland
²²Department of Hematooncology, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
²³Division of Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Department of Internal Medicine I, Ordensklinikum Linz, Linz, Austria
²⁴Faculty of Medicine, University of Belgrade, University Clinical Centre of Serbia, Belgrade, Serbia
²⁵First Department of Medicine, Klinik Ottakring, Vienna, Austria
²⁶Department of Haematology, University Hospital Galway, H91 Galway, Ireland; National University of Ireland, H91, Galway, Ireland
²⁷Oslo Myeloma Center, and KG Jebsen Center for B-cell Malignancies, University of Oslo, Oslo, Norway
²⁸Department Oncology/Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland, Zurich, CHE
²⁹Cantonal Hospital St. Gallen, St. Gallen, Switzerland
³⁰Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³¹Department of Lymphoma, Chinese Academy of Medical Sciences, Blood Diseases Hospital (Institute of Hematology), Tianjin, China
³²Department of Hematology, Hospital Alemán, Buenos Aires, Argentina
³³Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
³⁴University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
³⁵Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
³⁶IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
³⁷Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
³⁸Alfred Health-Monash University, Melbourne, VIC, Australia
³⁹Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
⁴⁰European Myeloma Network, EMN, Italy
⁴¹Health Data Specialists, Dublin, Ireland
⁴²Janssen Research& Development, LLC, Raritan, NJ
⁴³Janssen Research & Development, LLC, Raritan, NJ
⁴⁴Janssen Research & Development, LLC, Spring House, PA
⁴⁵Janssen Research & Development, LLC, Paris, France
⁴⁶Janssen Research & Development, LLC, High Wycombe, United Kingdom
⁴⁷Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁴⁸Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Anita D'Souza, MD, MS^1*, Luciano J. Costa, MD, PhD², Jesús F. San-Miguel, MD, PhD³, Jesus G Berdeja, MD⁴, Daniel Morillo Giles, MD^5*, Cyrille Touzeau, MD, PhD^6*, John T McKay, DO^7*, Bhagirathbhai R. Dholaria, MBBS⁸, Thomas G. Martin, MD⁹, Aurore Perrot, MD, PhD¹⁰, Albert Oriol^11*, Anna Sureda Balari, MD, PhD¹², Thomas Prior, PhD^13*, Debopriya Ghosh, PhD^14*, Lijuan Kang, PhD^13*, Julie S Larsen, PharmD^15*, Hein Ludlage, MSc^16*, Lien Vandenberk, PhD^17*, Lingling Chen, MD^13*, Bas D Koster, MD, PhD¹⁸, Weili Sun, PhD¹⁵, Rachel Kobos, MD¹⁹, Emma Searle, MD, PhD^20*, Jeffrey V Matous, MD²¹, Ajai Chari, MD⁹ and Tobias Kampfenkel, MD, MHBA^22*

¹Medical College of Wisconsin, Milwaukee, WI
²University of Alabama at Birmingham, Birmingham, AL
³Cancer Center Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain
⁴Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN
⁵START Madrid-FJD Early Phase Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain
⁶Centre Hospitalier Universitaire de Nantes, Nantes, France
⁷Wake Forest University School of Medicine, Winston-Salem, NC
⁸Vanderbilt University Medical Center, Nashville, TN
⁹University of California, San Francisco, San Francisco, CA
¹⁰Centre Hospitalier Universitaire de Toulouse, Oncopole, Toulouse, France
¹¹Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Baldona, Barcelona, Spain
¹²Institut Català d'Oncologia – Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain
¹³Janssen Research & Development, Spring House, PA
¹⁴Janssen Research & Development, Raritan, NJ
¹⁵Janssen Research & Development, Los Angeles, CA
¹⁶Janssen-Cilag Benelux, Leiden, Netherlands
¹⁷Janssen Research & Development, Antwerp, Belgium
¹⁸Janssen Biologics Europe, Leiden, Netherlands
¹⁹Janssen Research & Development, LLC, Raritan, NJ
²⁰The University of Manchester, Manchester, United Kingdom
²¹Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
²²Janssen Research & Development, Neuss, Germany

Cesar Rodriguez, MD^1*, Michal Mielnik, MD^2*, Dickran Kazandjian, MD³, Wojt Janowski, MD^4*, Michael S.Y. Low, MBBS, PhD⁵, Matthew Pianko⁶, Junichiro Yuda, MD, PhD^7*, Carrie Van Der Weyden, MBBS (Hons), FRACP, FRCPA^8*, Larry D Anderson Jr., MD, PhD⁹, Rahul Banerjee, MD, FACP¹⁰, Laura Rosinol Dachs, MD PhD^11*, Claudio Cerchione, MD¹², Malin Hultcrantz, MD¹³, Anita D'Souza, MD, MS^14*, Amandeep Godara¹⁵, Ariel Grajales-Cruz^16*, Ziyi Jin, MS^17*, Akshanth R Polepally, PhD^18*, Aarif Ahsan^17*, Shane Lee, MS^17*, Kristin D'Amico^17*, Orlando Bueno, MD, PhD¹⁷, Chetasi Talati, MD^19*, Anders Erik Svensson, MD^17*, Leanne Fleming, PhD^17*, Katja C. Weisel, MD²⁰, Marek Hus^21* and Peter M. Voorhees, MD²²

¹Division of Hematology-Oncology, Department of Internal Medicine, Mount Sinai, New York, NY
²Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
³Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁴Calvary Mater Newcastle, Newcastle, NSW, Australia
⁵School of Clinical Sciences at Monash Health, Monash University, Clayton, AUS
⁶Rogel Cancer Center, University of Michigan, Ann Arbor, MI
⁷National Cancer Center Hospital East, Kashiwa, Japan
⁸Department of Hematology, Peter MacCallum Cancer Center, Melbourne, VIC, AUS
⁹Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
¹⁰University of Washington, Fred Hutchinson Cancer Center, Seattle, WA
¹¹Hematology Department, Hospital Clinic de Barcelona and Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
¹²Hematology Unit, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS, Meldola (FC), Italy
¹³Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹⁵Huntsman Cancer Institute, Salt Lake City, UT
¹⁶Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁷AbbVie Inc., North Chicago, IL
¹⁸AbbVie Inc., Danville, CA
¹⁹AbbVie, Inc., North Chicago, IL
²⁰Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²¹Department of Hemato Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lubin, Poland
²²Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC

Saad Z. Usmani, MD¹, Michal Mielnik, MD^2*, Mamta Garg, MD^3*, Irwindeep Sandhu, MD^4*, Al-Ola Abdallah, MD⁵, Youngil Koh, MD, PhD⁶, Albert Oriol^7,8*, Hang Quach, MD, FRACP, FRCPA, MBBS⁹, Katja C. Weisel, MD¹⁰, Aranzazu Alonso Alonso, MD^11*, Enrique M Ocio, MD, PhD^8*, Wojciech Janowski, MD^12*, Chang-Ki Min^13*, Karthik Ramasamy¹⁴, Ricarda García Sánchez, MD^15*, Paula Rodríguez-Otero, MD, PhD^16*, Chris Brawley, MSc^17*, Jacqueline L Egger, PhD^17*, Morrys C Kaisermann, MD, PhD^18* and Marek Hus, MD, PhD^19*

¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
³Leicester Royal Infirmary, Leicester, United Kingdom
⁴University of Alberta, Edmonton, AB, Canada
⁵US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
⁶Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Baldona, Barcelona, Spain
⁸Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
⁹St. Vincent's Hospital Melbourne, East Melbourne, Australia
¹⁰University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
¹¹Hospital Universitario Quirónsalud Madrid, Madrid, Spain
¹²Calvary Mater Newcastle, Newcastle, NSW, Australia
¹³Department of Hematology, Seoul St. Mary's Hospital,The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁴Oxford Translational Myeloma Centre, NDORMS, University of Oxford and Churchill Hospital, Headington, Oxford, United Kingdom
¹⁵Department of Hematology, Hospital Virgen de la Victoria, Málaga, Spain
¹⁶Clinica Universidad de Navarra, Madrid, Spain
¹⁷GSK, London, United Kingdom
¹⁸GSK, Upper Providence, PA
¹⁹Medical University of Lublin, Lublin, Poland

Peter T. Tan, MBBS¹, LI Bao^2*, Qingsong Yin, PhD^3*, Chunrui Li^4*, Sorab Jehangir Shavaksha^5*, H. Miles Prince^6*, Zhen Cai^7*, SHAN GAO, PhD, MD^8*, Qian Wang^3*, Di Wang^4*, YI LI^9*, Mingfei Zhang^10*, Qiumei Deng^11*, Qiaoyang Lu^10*, Chengjun Jiang^10*, Fang Ren^10*, Danqing Wu^10*, Shuqi Zeng^10*, Yonghong Zhu^10*, Yi Tao^12*, Yuanfang Liu, MD, PhD^13* and Jian-Qing Mi¹²

¹One Clinical Research Pty Ltd, Nedlands, Australia
²Beijing Jishuitan Hospital, Beijing, Beijing, CHN
³Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology, China, Wuhan, China
⁵5Sunshine Coast Haematology and Oncology Clinic (SCHOC), Australia, Buderim, QLD, Australia
⁶Epworth Healthcare and University of Melbourne, Melbourne, VIC, Australia
⁷Department of Haematology, First Affiliated Hospital of Zhejiang University, Hangzhou, China
⁸Beijing Jishuitan Hospital, Beijing, Beijing, China
⁹The First Affiliated Hospital, Zhejiang University School of Medicine, China, Hangzhou, China
¹⁰Shanghai EpimAb Biotherapeutics, Shanghai, China, Shanghai, China
¹¹Epimab Biotherapeutics, Shanghai, China
¹²Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
¹³Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China